Advancing extracellular vesicle production: improving physiological relevance and yield with 3D cell culture
Nanoscale · 2025 · 17 (25) · 15110-15131
DOI: 10.1039/d5nr00707k ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2025. Verfasst von Kara Cook und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering, University of Guelph, Guelph, Ontario, Canada N1G2W1. huiyanli@uoguelph.ca. Hauptthemen laut MEDLINE: Extracellular Vesicles, Cell Culture Techniques, Cell Culture Techniques, Three Dimensional. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Cancer Research Society, Canadian Institutes of Health Research, University of Guelph.
Abstract (Originalsprache)
3D cell cultures produce higher EV yields, with comparable or more physiologically relevant morphology, enriched cargo, and enhanced functionality. However, each model presents distinct strengths and limitations that must be carefully considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Engineering, University of Guelph, Guelph, Ontario, Canada N1G2W1. huiyanli@uoguelph.ca.
Förderung
- Cancer Research Society
- Canadian Institutes of Health Research
- University of Guelph
Zitieren
APA
Cook, K., & Li, H. (2025). Advancing extracellular vesicle production: improving physiological relevance and yield with 3D cell culture. Nanoscale, 17(25), 15110-15131. https://doi.org/10.1039/d5nr00707k
Vancouver
Cook K, Li H. Advancing extracellular vesicle production: improving physiological relevance and yield with 3D cell culture. Nanoscale. 2025;17(25):15110-15131. doi:10.1039/d5nr00707k
BibTeX
@article{Cook2025,
author = {Cook, Kara and Li, Huiyan},
title = {Advancing extracellular vesicle production: improving physiological relevance and yield with 3D cell culture},
journal = {Nanoscale},
year = {2025},
volume = {17},
number = {25},
pages = {15110--15131},
doi = {10.1039/d5nr00707k}
}
EUVIMED